The University of Arizona

Chronic Obstructive Pulmonary Disease (COPD)

Summary: 

Early Treatment with Tiotropium in Patients Recovering from Hospitalization for COPDThis study aims to assess the safety and effectiveness of tiotropium bromide delivered via the HandiHaler® in Chronic Obstructive Pulmonary Disease (COPD) subjects recovering from hospitalization for COPD.

Sponsor: 
Boehringer Ingelheim Pharmaceuticals


Research Specialties: 
Pulmonary


Fatal error: Class 'FeedsHTTPCache' not found in /home/arcadmin/public_html/sites/all/modules/feeds/feeds.module on line 82